Northern Trust Corp Coh Bar, Inc. Transaction History

Northern Trust Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$0.34 - $1.0 $1,400 - $4,120	-4,120 Reduced 4.33%	90,923 $32,000
Q2 2021 Aug 13, 2021	SELL	$1.09 - $1.49 $263,447 - $360,125	-241,695 Reduced 71.78%	95,043 $133,000
Q1 2021 May 12, 2021	SELL	$1.26 - $2.02 $35,089 - $56,254	-27,849 Reduced 7.64%	336,738 $458,000
Q4 2020 Feb 11, 2021	BUY	$0.9 - $1.54 $58,167 - $99,531	64,631 Added 21.55%	364,587 $489,000
Q3 2020 Nov 16, 2020	SELL	$0.87 - $2.08 $4,779 - $11,427	-5,494 Reduced 1.8%	299,956 $284,000
Q2 2020 Aug 14, 2020	BUY	$1.08 - $4.0 $268,344 - $993,868	248,467 Added 436.04%	305,450 $474,000
Q3 2019 Nov 13, 2019	SELL	$1.3 - $1.76 $253,831 - $343,648	-195,255 Reduced 77.41%	56,983 $74,000
Q2 2019 Aug 13, 2019	SELL	$1.63 - $3.3 $25,454 - $51,532	-15,616 Reduced 5.83%	252,238 $434,000
Q1 2019 May 13, 2019	SELL	$2.95 - $4.16 $2,380 - $3,357	-807 Reduced 0.3%	267,854 $873,000
Q4 2018 Feb 12, 2019	SELL	$2.97 - $4.52 $10,403 - $15,833	-3,503 Reduced 1.29%	268,661 $836,000
Q3 2018 Nov 14, 2018	BUY	$4.13 - $6.84 $92,326 - $152,908	22,355 Added 8.95%	272,164 $1.17 Million
Q2 2018 Aug 14, 2018	BUY	$4.44 - $10.4 $1.11 Million - $2.6 Million	249,809 New	249,809 $1.64 Million

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.19M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.